Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study
- Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group
- University of Duisburg-Essen
- University of Miami
- Hamilton Health Sciences
- Boehringer Ingelheim GmbH
- Medical University of South Carolina
- Stanford University
- University of Nottingham
- Ichilov Medical Center
- National University Hospital
- Chang Gung Memorial Hospital
- University of Coimbra
- Sahlgrenska University Hospital
- University of Groningen
- University of Melbourne
- Neurological Center for Treatment and Research
- University of Illinois at Chicago
- Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd.
- Boehringer Ingelheim AB
- HUS Helsinki University Hospital
- Fudan University
- St. John's National Academy of Health Sciences
- McMaster University
- Pirogov Russian National Research Medical University
- University of British Columbia
- University of Rome La Sapienza
- SUNY Downstate Health Sciences University
- Seoul National University
研究成果: 期刊稿件 › 文章 › 同行評審
318
引文
斯高帕斯（Scopus）